Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study
Open Access
- 27 December 2012
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 16 (6) , R238
Abstract
Introduction: Streptococcus pneumoniae is the most common causative pathogen in community-acquired pneumonia. Protease-activated receptor-1 (PAR-1) is expressed by multiple cell types present in the lungs and can be activated by various proteases generated during acute inflammation. The cellular effect of PAR-1 activation partially depends on the specific protease involved. We here determined the role of PAR-1 in the host response during murine pneumococcal pneumonia. Methods: Wild-type (WT) and PAR-1 knockout (KO) mice were infected intranasally with viable S. pneumoniae and observed in a survival study or euthanized at 6, 24 or 48 hours of infection. Results: PAR-1 KO mice had a better survival early after infection compared to WT mice. Moreover, PAR-1 KO mice had lower bacterial loads in lungs and blood at 24 hours and in spleen and liver at 48 hours after infection. This favorable response was accompanied by lower lung histopathology scores and less neutrophil influx in PAR-1 KO mice. Conclusion: PAR-1 impairs host defense during murine pneumococcal pneumonia.Keywords
This publication has 24 references indexed in Scilit:
- Protease‐activated receptors and prostaglandins in inflammatory lung diseaseBritish Journal of Pharmacology, 2009
- Concentration dependent dual effect of thrombin in endothelial cells via Par‐1 and Pi3 KinaseJournal of Cellular Physiology, 2009
- The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cellsBlood, 2007
- 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damageNature Immunology, 2007
- A novel therapeutic target in various lung diseases: Airway proteases and protease-activated receptorsPharmacology & Therapeutics, 2007
- Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*Critical Care Medicine, 2005
- PAR1 Cleavage and Signaling in Response to Activated Protein C and ThrombinJournal of Biological Chemistry, 2005
- Protease-Activated Receptors: Contribution to Physiology and DiseasePhysiological Reviews, 2004
- Guidelines for the Management of Adults with Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000